DITRA

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

9Recruiting trials

Regulatory Watchboard

10 events

May 2026Generalized Pustular Psoriasis Registry in Costa Rica

Caja Costarricense de Seguro Social

TrialNOT YET RECRUITING

Mar 2026A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — PHASE2

TrialRECRUITING

Jan 2025A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Bristol-Myers Squibb

TrialACTIVE NOT RECRUITING

Sep 2024Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis

Shanghai Huaota Biopharmaceutical Co., Ltd. — PHASE2, PHASE3

TrialRECRUITING

Jun 2024A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. — PHASE1

TrialACTIVE NOT RECRUITING

Mar 2024A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Takeda — PHASE3

TrialACTIVE NOT RECRUITING

Feb 2024A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Janssen Pharmaceutical K.K. — PHASE3

TrialACTIVE NOT RECRUITING

Oct 2023A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares

Boehringer Ingelheim — PHASE4

TrialACTIVE NOT RECRUITING

Oct 2023Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Innovaderm Research Inc.

TrialRECRUITING

Sep 2023CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

CorEvitas

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for DITRA.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Kineret

(anakinra)Orphan drug

Swedish Orphan Biovitrum AB (publ)

Interleukin-1 Receptor Antagonist [EPC]

12.1 Mechanism of Action KINERET blocks the biologic activity of IL-1 alpha and beta by competitively inhibiting IL-1 binding to the interleukin-1 typ...

Approved Dec 2020FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

9 active trials

2Phase 3

1Phase 4

2Phase 2

1Phase 1

2Unknown

1PHASE2, PHASE3

9Total recruiting

Search clinical trials for DITRA →

Recent News & Research

No recent news articles indexed yet for DITRA.
Search PubMed for DITRA →

Browse all DITRA news →

Specialist Network

Top 6 by expertise

Jianzhong Zhang, PhD, M.D

Peking University People's Hospital (PKUPH)

📍 HAMPTON, VA

Score 442 trials

Robert Bissonnette, MD

Innovaderm Research

Score 166 trials

Edward W Cowen, M.D., M.D

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

📍 SILVER SPRING, MD

Score 92 trials

Bristol Myers Squibb

Bristol-Myers Squibb

Score 811 trials

Robert Bissonnette, MD MSc FRCPC

Innovaderm Research Incorporated

Score 62 trials

Antonio Martorell, PhD

Hospital Universitari de Manises

Score 53 trials

View all DITRA specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles